Theravance Biopharma (TBPH) Asset Utilization Ratio (2016 - 2025)
Theravance Biopharma (TBPH) has disclosed Asset Utilization Ratio for 12 consecutive years, with 0.19 as the latest value for Q3 2025.
- On a quarterly basis, Asset Utilization Ratio rose 11.79% to 0.19 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.19, a 11.79% increase, with the full-year FY2020 number at 0.16, up 8.04% from a year prior.
- Asset Utilization Ratio was 0.19 for Q3 2025 at Theravance Biopharma, down from 0.2 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.21 in Q2 2021 to a low of 0.06 in Q4 2022.
- A 5-year average of 0.15 and a median of 0.16 in 2024 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: plummeted 66.99% in 2021, then skyrocketed 81.75% in 2023.
- Theravance Biopharma's Asset Utilization Ratio stood at 0.19 in 2021, then crashed by 68.14% to 0.06 in 2022, then surged by 113.7% to 0.13 in 2023, then skyrocketed by 43.05% to 0.18 in 2024, then grew by 5.31% to 0.19 in 2025.
- Per Business Quant, the three most recent readings for TBPH's Asset Utilization Ratio are 0.19 (Q3 2025), 0.2 (Q2 2025), and 0.19 (Q1 2025).